Meningococcal Vaccine Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Meningococcal Vaccine Market contains market size and forecasts of Meningococcal Vaccine in global, including the following market information:

Global Meningococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meningococcal Vaccine Market Sales, 2017-2022, 2023-2028, (10K Pcs)

Global top five Meningococcal Vaccine companies in 2021 (%)

The global Meningococcal Vaccine market was valued at 269.6 million in 2021 and is projected to reach US$ 359.8 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Meningtits A Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meningococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)

Global Meningococcal Vaccine Market Segment Percentages, by Type, 2021 (%)

Meningtits A

Polysaccharide Meningtitis AC

Meningitis ACYW

Global Meningococcal Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)

Global Meningococcal Vaccine Market Segment Percentages, by Application, 2021 (%)

6 Months-15Year

over 3 Year

over 2 Year

over 3 Months

Global Meningococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)

Global Meningococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meningococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Meningococcal Vaccine revenues share in global market, 2021 (%)

Key companies Meningococcal Vaccine sales in global market, 2017-2022 (Estimated), (10K Pcs)

Key companies Meningococcal Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis

GSK

Merck

CSL

Baxter

JN International Medical Corporation

Serum Institute of India

Bio-Med

China National Biotec Group

Hualan Bio

Walvax

Zhifei